Accuray Incorporated (LON:0H8I)
2.095
-0.060 (-2.78%)
At close: Feb 21, 2025
Accuray Revenue
Accuray had revenue of $116.17M USD in the quarter ending December 31, 2024, with 8.33% growth. This brings the company's revenue in the last twelve months to $453.14M, up 1.26% year-over-year. In the fiscal year ending June 30, 2024, Accuray had annual revenue of $446.55M, down -0.24%.
Revenue (ttm)
$453.14M
Revenue Growth
+1.26%
P/S Ratio
n/a
Revenue / Employee
$459.11K
Employees
987
Market Cap
171.64M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 446.55M | -1.05M | -0.24% |
Jun 30, 2023 | 447.61M | 17.70M | 4.12% |
Jun 30, 2022 | 429.91M | 33.62M | 8.48% |
Jun 30, 2021 | 396.29M | 13.36M | 3.49% |
Jun 30, 2020 | 382.93M | -35.86M | -8.56% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
Hikma Pharmaceuticals | 2.39B |
ConvaTec Group | 1.74B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
Accuray News
- 17 days ago - Accuray Inc (ARAY) Q2 2025 Earnings Call Highlights: Strong Product Revenue and Strategic ... - GuruFocus
- 17 days ago - Accuray raises FY 2025 revenue guidance to $463M-$475M, driven by strong China growth - Seeking Alpha
- 17 days ago - Accuray Incorporated (ARAY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Accuray Inc Q2 Earnings: EPS of $0.03 Beats Estimate, Revenue Surpasses Expectations at $116. ... - GuruFocus
- 17 days ago - Accuray GAAP EPS of $0.02 beats by $0.05, revenue of $116.2M beats by $5.84M - Seeking Alpha
- 17 days ago - Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance - PRNewsWire
- 17 days ago - Accuray (ARAY) Stock Surges Amidst Market Activity - GuruFocus
- 4 weeks ago - Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product - PRNewsWire